Arrigoni Sara Camilla, Kuijpers Michiel, Mecozzi Gianclaudio, Mariani Massimo Alessandro
Thoraxcenter, Medisch Spectrum Twente, Enschede, The Netherlands.
Interact Cardiovasc Thorac Surg. 2011 Jun;12(6):891-4. doi: 10.1510/icvts.2010.257576. Epub 2011 Mar 1.
The PulseCath(®) is a pulsatile pump that offers a circulatory support up to 3 l/min. The PulseCath(®) is indicated for patients who require a higher degree of support than that offered by the intra-aortic balloon pump. We describe the first two cases of the use of the PulseCath(®) as a temporary support for the right ventricle after insertion through the pulmonary artery trunk. Two patients developed an acute right ventricular failure with severe hemodynamic instability after cardiac surgery. The PulseCath(®) was chosen to assist the right ventricle. An immediate improvement of hemodynamic parameters was observed in both cases. In the first patient an irreversible metabolic unbalance, already present prior to PulseCath(®) insertion, led to multi-organ failure and eventually to death. In the second case the early utilization of PulseCath(®) led to a complete recovery of the right ventricle and the patient was discharged in good clinical condition. Besides the technical feasibility, this report would suggest that a correct timing is the key to success for the PulseCath(®) as a right ventricular assist device.
PulseCath(®)是一种搏动泵,可提供高达3升/分钟的循环支持。PulseCath(®)适用于那些需要比主动脉内球囊泵提供的支持程度更高的患者。我们描述了通过肺动脉主干插入后使用PulseCath(®)作为右心室临时支持的前两例病例。两名患者在心脏手术后出现急性右心室衰竭并伴有严重的血流动力学不稳定。选择PulseCath(®)来辅助右心室。在这两例病例中均观察到血流动力学参数立即得到改善。在第一例患者中,在插入PulseCath(®)之前就已存在的不可逆代谢失衡导致多器官功能衰竭并最终死亡。在第二例病例中,早期使用PulseCath(®)导致右心室完全恢复,患者出院时临床状况良好。除了技术可行性外,本报告表明正确的时机是PulseCath(®)作为右心室辅助装置取得成功的关键。